Comparison of the Cellular Composition and Cytokine-Release Kinetics of Various Platelet-Rich Plasma Preparations
- PMID: 26473014
- DOI: 10.1177/0363546515608481
Comparison of the Cellular Composition and Cytokine-Release Kinetics of Various Platelet-Rich Plasma Preparations
Abstract
Background: Variations in formulations used to prepare platelet-rich plasmas (PRPs) result in differences in the cellular composition and biomolecular characteristics.
Purpose: To evaluate the cellular composition and the cytokine-release kinetics of PRP according to differences in the preparation protocols.
Study design: Controlled laboratory study.
Methods: Five preparation procedures were performed for 14 healthy subjects, including 2 manual procedures (single-spin [SS] at 900 g for 5 minutes; double-spin [DS] at 900 g for 5 minutes and then 1500 g for 15 minutes) and 3 methods with commercial kits (Arthrex ACP, Biomet GPS, and Prodizen Prosys). After evaluation of cellular composition, each preparation was divided into 4 aliquots and incubated for 1 hour, 24 hours, 72 hours, and 7 days for the assessment of cytokine release over time. The cytokine-release kinetics were evaluated by assessing platelet-derived growth factor (PDGF), transforming growth factor (TGF), vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), interleukin-1 (IL-1), and matrix metalloproteinase-9 (MMP-9) concentrations of each aliquot with bead-based sandwich immunoassay.
Results: The DS PRP had a higher concentration of platelets and leukocytes than did the SS PRP. Every PRP preparation exhibited an increase in PDGF, TGF, VEGF, and FGF release when compared with whole blood samples. The FGF and TGF release occurred quickly and decreased over time, while the PDGF and VEGF release was constant and sustained over 7 days. The PDGF and VEGF concentrations were higher in the DS PRP than in the SS PRP, whereas the TGF and FGF concentrations were higher in the SS PRP than in the DS PRP. Biomet GPS had the highest VEGF and MMP-9 concentrations but the lowest TGF concentration. Arthrex ACP had the highest FGF concentration but the lowest PDGF concentration. Prodizen Prosys had the highest IL-1 concentration and higher PDGF concentration than Arthrex ACP.
Conclusion: The DS method generally led to a higher concentration of platelet relative to the SS method. However, the cytokine content was not necessarily proportional to the cellular composition of the PRPs, as the greater content could be different between the SS or DS method depending on the type of cytokine.
Clinical relevance: Physicians should select proper PRP preparations after considering their biomolecular characteristics and patient indications.
Keywords: cell composition; cytokine-release kinetics; platelet-rich plasma; preparations.
© 2015 The Author(s).
Similar articles
-
Leukocyte concentration and composition in platelet-rich plasma (PRP) influences the growth factor and protease concentrations.J Orthop Sci. 2016 Sep;21(5):683-9. doi: 10.1016/j.jos.2016.07.009. Epub 2016 Aug 5. J Orthop Sci. 2016. PMID: 27503185
-
Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma.Am J Sports Med. 2011 Oct;39(10):2135-40. doi: 10.1177/0363546511417792. Epub 2011 Aug 16. Am J Sports Med. 2011. PMID: 21846925
-
Cytokine-release kinetics of platelet-rich plasma according to various activation protocols.Bone Joint Res. 2016 Feb;5(2):37-45. doi: 10.1302/2046-3758.52.2000540. Bone Joint Res. 2016. PMID: 26862077 Free PMC article.
-
Concentrations of Blood Components in Commercial Platelet-Rich Plasma Separation Systems: A Review of the Literature.Am J Sports Med. 2019 Feb;47(2):479-487. doi: 10.1177/0363546517746112. Epub 2018 Jan 16. Am J Sports Med. 2019. PMID: 29337592 Review.
-
Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich fibrin (L-PRF).Curr Pharm Biotechnol. 2012 Jun;13(7):1145-52. doi: 10.2174/138920112800624382. Curr Pharm Biotechnol. 2012. PMID: 21740377 Review.
Cited by
-
Harmony in Healing: Investigating Platelet-Rich Plasma Activation during Acetylsalicylic Acid Treatment.Int J Mol Sci. 2024 Oct 14;25(20):11037. doi: 10.3390/ijms252011037. Int J Mol Sci. 2024. PMID: 39456821 Free PMC article.
-
Leucocyte-poor-platelet-rich plasma intra-operative injection in chondral knee injuries improve patients outcomes. A prospective randomized trial.Int Orthop. 2021 Feb;45(2):463-471. doi: 10.1007/s00264-020-04830-4. Epub 2020 Sep 29. Int Orthop. 2021. PMID: 32990794 Clinical Trial.
-
Redifferentiation of Articular Chondrocytes by Hyperacute Serum and Platelet Rich Plasma in Collagen Type I Hydrogels.Int J Mol Sci. 2019 Jan 14;20(2):316. doi: 10.3390/ijms20020316. Int J Mol Sci. 2019. PMID: 30646566 Free PMC article.
-
Growth factor levels in leukocyte-poor platelet-rich plasma and correlations with donor age, gender, and platelets in the Japanese population.J Exp Orthop. 2019 Feb 2;6(1):4. doi: 10.1186/s40634-019-0175-7. J Exp Orthop. 2019. PMID: 30712144 Free PMC article.
-
A randomized, double-blind, vehicle-controlled clinical study of hair regeneration using adipose-derived stem cell constituent extract in androgenetic alopecia.Stem Cells Transl Med. 2020 Aug;9(8):839-849. doi: 10.1002/sctm.19-0410. Epub 2020 May 18. Stem Cells Transl Med. 2020. PMID: 32420695 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous